Search results
Author(s):
Rajesh Kharbanda
Added:
8 months ago
EuroPCR 25 - A meta-analysis of the individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies show TAVI with cerebral embolic protection (CEP) may reduce the rate of disabling stroke compared to TAVI without CEP.We are joined by Prof Rajesh Kharbanda (Oxford Radcliffe Hospitals NHS Trust, Oxford, UK) to discuss outcomes from a meta-analysis investigating TAVI with or without…
View more
Stenting Strategies in Left Main Bifurcation
Author(s):
Suryono Suryono
,
Muhammad Farhan Hibatulloh
,
Alfiyah Ramadhani
,
et al
Added:
2 days ago
Systematic Review
Management of CAD in TAVI
Author(s):
Cian Murray
,
Caoimhe Ryan
,
Michael Cronin
,
et al
Added:
8 months ago
Systematic Review
Author(s):
Gianluca Campo
Added:
1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in…
View more
PCI Strategies for Calcified Lesions: Systematic Review
Author(s):
Andreas Torp Kristensen
,
Pascal Faltermeier
,
Caroline Barkholt Kamp
,
et al
Added:
2 months ago
Systematic Review
Author(s):
Raj Makkar
Added:
8 months ago
EuroPCR 25 - Post-hoc anlysis outcomes from under-expansion of the ACURATE neo2 valve in severe aortic stenosis (AS) patients show under-expansion was associated with higher rates of death, stroke or rehospitalisation.We are joined by Dr Raj Makkar (Cedars-Sinai Heart Institute, Los Angeles, US) to discuss findings from the post-hoc analysis of the ACURATE IDE study (NCT03735667; Boston…
View more
Author(s):
Brian Lindman
Added:
10 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in…
View more
Author(s):
Didier Tchétché
Added:
1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of transcatheter aortic valve replacement (TAVR) compared to surgical aortic valve replacement (SAVR) in female patients with severe aortic stenosis.Dr Didier Tchétché (Clinique Pasteur, FR) joins us onsite at TCT Conference to discuss the pooled findings from the RHEIA (NCT04160130) and PARTNER 3 (NCT02675114) trials.RHEIA and PARTNER 3 are…
View more
Anna Meta Dyrvig Kristensen
Job title: MB
Author
Author(s):
Spyros Mavropoulos
Added:
2 years ago